Hvad er Y-tunnus-nummeret på BiopSense Oy?

BiopSense Oy er registreret hos PRH / YTJ under Y-tunnus 2958574-3.

Hvad er omsætningen for BiopSense Oy?

BiopSense Oy rapporterede en omsætning på EUR 117K i 2025.

Hvor mange medarbejdere har BiopSense Oy?

BiopSense Oy beskæftiger 11 personer pr. seneste årsrapport.

Hvem er administrerende direktør i BiopSense Oy?

Jussi Tapani Pennanen er Chief Executive Officer i BiopSense Oy, i rollen siden 2019.

Hvem er bestyrelsesformand i BiopSense Oy?

Jukka-Pekka Nikula er bestyrelsesformand i BiopSense Oy, i rollen siden 2026.

Hvor har BiopSense Oy hovedsæde?

BiopSense Oys registrerede adresse er Eeronkatu 10.

Riskpilot← Tilbage til søgning

Log indFå fuld adgang

BiopSense Oy

OYActive

Y-tunnus 2958574-3Eeronkatu 10, 40720 JyväskyläDiagnostic imaging services and medical laboratory activities · NACE 8691Est. 201811 employeeswww.biopsense.com

Overview Financials People & ownership Related companies

Financials

Revenue

EUR millions

EBITDA

EUR millions

Income statement

EUR thousands

Item	2021	2022	2023	2024	2025
Revenue	4 636	704	41	61	117
Staff expenses	−850	−693	−712	−411	−409
EBITDA	994	−378	−199	−314	−299
Depreciation & amort.	−39	−68	−73	−60	−51
EBIT	955	−447	−272	−375	−350
Net financials	−6	−3	−0	−21	−87
Profit before tax	949	−450	−272	−396	−437
Tax	169	5	−0	−0	−0
Net profit	780	−455	−272	−396	−437

Balance sheet

EUR thousands

Item	2021	2022	2023	2024	2025
Total assets	954	1 769	916	1 890	2 452
Equity	677	169	128	582	470
Long-term debt	1	—	0	1 017	1 649
Short-term debt	276	1 600	788	291	333
Total debt	277	1 600	788	1 307	1 982

Financial ratios

5-year trend

EBITDA-margin

-255.3%

This company

15.8%

Market median

-1716% vs market

20212025

Soliditetsgrad

19.2%

This company

38.2%

Market median

-50% vs market

20212025

Egenkapitalforrentning

-93.0%

This company

18.4%

Market median

-605% vs market

20212025

Nettoresultatgrad

-373.6%

This company

8.1%

Market median

-4712% vs market

20212025

Aktivomsætning

0.05×

This company

1.12×

Market median

-96% vs market

20212025

Gæld/egenkapital

4.21×

This company

0.62×

Market median

-579% vs market

20212025

Annual reports & filings

Annual report 2025
Filed via PRH / YTJ · Period 2024-12-01 – 2025-11-30
View PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-12-01 – 2024-11-30
View PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-12-01 – 2023-11-30
View PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-12-01 – 2022-11-30
View PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-06-01 – 2021-11-30
View PDF

BiopSense Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on BiopSense Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on BiopSense Oy